Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
DescriptionVenture Capital






SR One

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately $600 million in more than 130 companies. For more information please visit

Recent Milestones


Company Date Round Size Participants
Alios BioPharma 4/2014Series B$41M4
RuiYi 3/2014Series B$15M6
ZappRx 1/2014Seed$1M6
MISSION Therapeutics 11/2013Series B£20M4
Aileron Therapeutics 11/2013Series E$30M6
f-star Biotech 10/2013Series A$9.4M6
Auxogyn 9/2013Series B$5.53M4
iPierian 9/2013Series A$30M3
Dicerna Pharmaceuticals 7/2013Series C$60M9
Effector Therapeutics 5/2013Venture Round$45M7
Aileron Therapeutics 1/2013Series D$12M6
River Vision Development 12/2012Series A$17M3
Bicycle Therapeutics 12/2012Venture Round£3.75M5
Applied Genetics Technologies Corporation 11/2012Series B$37.5M6
Principia BioPharma 10/2012Series A$12.5M5
Thrasos 10/2012Series C$35M7
Genocea Biosciences 10/2012Series C$30M10
IlluminOss Medical 9/2012Series C$28M9
Auxogyn 6/2012Series B$18M4
RaNA Therapeutics 1/2012Series A$20.7M3
MISSION Therapeutics 8/2011Venture Round$10M4
Nimbus Discovery 6/2011Series A$24M3
HTG Molecular Diagnostics 6/2011Series D$500k1
Constellation Pharmaceuticals 6/2011Series B$15M5
f-star Biotech 4/2011Venture Round€15M7
Genocea Biosciences 1/2011Series B$35M9
Semprus BioSciences 12/2010Series B$18M5
Syntaxin 11/2010Series C$29M7
iPierian 11/2010Series B$29M8
Dicerna Pharmaceuticals 10/2010Series B$4M2
Constellation Pharmaceuticals 6/2010Series B$22.3M5
NeuroTherapeutics Pharma 5/2010Series B$43M4
CalciMedica 12/2009Series C$12M3
Trinity Biosystems 11/2009Debt$7.5M5
Aileron Therapeutics 6/2009Series D$40M6
Anaphore 6/2009Series A$13M5
Melinta 1/2009Private Equity$25M8
CalciMedica 1/2009Series C$4M3
POINT Biomedical 1/2008Series E$25M4
Syntaxin 10/2007Series B$32M5
CalciMedica 7/2007Series A$1.5M1
Onyvax 5/2006Series C£8M5



  1. Alios BioPharma Completes $41M Series B Financing ( [edit]
  2. RuiYi Raises $15m Series B Financing ( [edit]
  3. ZappRx Raises $1M in Seed Funding ( [edit]
  4. Imperial Innovations Group plc : MISSION Therapeutics receives £20m Series B funding ( [edit]
  5. Aileron Therapeutics Secures $30M in Series E Equity Financing ( [edit]
  6. F-star Alpha Raises €9.4M in Series A Funding ( [edit]
  7. SEC ( [edit]
  8. iPierian Raises $30M; Funds True North Therapeutics ( [edit]
  9. Dicerna Pharmaceuticals Raises $60M In Series C Financing ( [edit]
  10. Effector Therapeutics snags $45M venture round from A-list backers ( [edit]
  11. Aileron Therapeutics Raises $12M in Series D Financing ( [edit]
  12. River Vision Announces Completion of $17 million Series A Financing ( [edit]
  13. Bicycle Therapeutics Raises £3.75M in Funding ( [edit]
  14. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding ( [edit]
  15. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team ( [edit]
  16. Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury ( [edit]
  17. Genocea raises $30M to advance herpes vaccine ( [edit]
  18. IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair ( [edit]
  19. Auxogyn Raises $18M in Series B Financing ( [edit]
  20. RaNA Therapeutics emerges from stealth with $20.7M Series A round ( [edit]
  21. MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth ( [edit]
  22. Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery ( [edit]
  23. HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing ( [edit]
  24. Constellation Pharmaceuticals Raises $15M in Series B Financing ( [edit]
  25. f-star raises €15M in a New Financing led by SR One ( [edit]
  26. Genocea Biosciences Closes $35M Series B Financing Round ( [edit]
  28. VCs inject $29M into Syntaxin, $11.5M into Ceregene ( [edit]
  29. SEC ( [edit]
  30. Dicerna makes $29M second close on Series B funding round ( [edit]
  31. SEC ( [edit]
  32. Big Pharma firms back $43M round for NeuroTherapeutics ( [edit]
  33. CalciMedica Closes Second Tranche of $12M Series C Financing ( [edit]
  34. SEC D/A ( [edit]
  35. Aileron Therapeutics Closes Series D Financing ( [edit]
  36. Anaphore, Inc.: Series A $13M ( [edit]
  37. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing ( [edit]
  38. CalciMedica, Inc.: Series C $4M ( [edit]
  39. Capital Funding Report [edit]
  40. Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline ( [edit]
  41. CalciMedica raises $1.5M for inflammatory disease ( [edit]
  42. Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine ( [edit]
Edit This Page
Last Edited 4/7/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy